TAP
BSX icon

Tounjian Advisory Partners’s Boston Scientific BSX Stock Holding History

Tounjian Advisory Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8K Sell
299
-14,789
-98% -$803K 0.01% 349
2026
Q1 		$947K Sell
15,088
-404
-3% -$32.3K 0.34% 105
2025
Q4 		$1.48M Buy
+15,492
New +$1.52M 0.5% 67

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Tounjian Advisory Partners's BSX Position: Q2 2026 in Review

Tounjian Advisory Partners reduced its Boston Scientific (BSX) stake by 98% in Q2 2026, selling an estimated $803K and leaving 299 shares worth $12.8K. The position accounts for 0.01% of the portfolio, ranked #349.

Tounjian Advisory Partners first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.48M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Tounjian Advisory Partners held 299 shares of Boston Scientific worth $12.8K as of Q2 2026.
  • Tounjian Advisory Partners sold 14,789 Boston Scientific shares in Q2 2026, an estimated $803K.
  • Boston Scientific made up 0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #349 holding.
  • Tounjian Advisory Partners first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Tounjian Advisory Partners's Boston Scientific position peaked at $1.48M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.